List of Top Open Peer-reviewed Journals in Cancer (2024)
- May 15, 2024
- Posted by: IRP Academy
- Category: Journals
List of Top Open Peer-reviewed Journals in Cancer (2024)
- Current Oncology(Optional Open-peer-reviewed)
- Cancers(Optional Open-peer-reviewed)
- Asian Oncology Research Journal
- Hereditary Cancer in Clinical Practice
- Computational and Systems Oncology
- Brazilian Journal of Cancerology
- International Research Journal of Oncology
- Hereditary Cancer in Clinical Practice
- Journal of Cancer and Tumor International
- Molecular Oncology
- Journal of Advances in Medicine and Medical Research
What is open peer review?
Open peer review (OPR), where review reports and reviewers’ identities are published alongside the articles, represents one of the last aspects of the open science movement to be widely embraced, although its adoption has been growing since the turn of the century (Wolfram etal., 2020) . Open peer review refers to various modifications of the traditional scholarly peer review process. These modifications aim to address perceived shortcomings of the conventional system. Here are the three common forms of open peer review:
- Open Identities:
- In open peer review, authors and reviewers are aware of each other’s identities. Unlike traditional peer review, where reviewers remain anonymous to anyone but the journal’s editors, open peer review allows transparency by revealing reviewer names to authors.
- However, reviewer identities may or may not be disclosed to the public.
- Open Reports:
- Under this model, review reports are made public, rather than being confidentially shared only with the article’s authors. This includes publishing not only the reviewers’ comments but also the authors’ responses and editors’ recommendations.
- Typically, this applies to articles accepted for publication, not those that are rejected.
- Open Participation:
- In open peer review, self-selected reviewers (beyond invited experts) can comment on an article. The assumption is that the article’s content is openly accessible.
- These self-selected reviewers may contribute either brief comments or comprehensive reviews.
- The text of the article is openly available, allowing broader community participation in the review process.
The adoption of open peer review aims to enhance transparency, provide incentives, reduce wastefulness, and address issues like bullying and harassment in scholarly communication.
What are the benefits of Open Peer Review?
Open peer review (OPR) is a transparent process that allows scholarly articles to be evaluated by experts in the field, while also revealing the identities of both authors and reviewers. OPR can improve the quality of research by:
- Encouraging constructive feedback: Openness in the identities of authors and reviewers can lead to better quality feedback rather than simply rejecting the paper.
- Reducing bias: Everything is openly available to all, which can reduce the possibility of bias.
- Empowering authors: Authors can lead the process by suggesting reviewers themselves.
- Improving accountability: The quality of current scientific publications is at stake.
- Encouraging collaboration: OPR encourages collaboration and promotes diversity of perspectives, ultimately leading to more robust and credible research outcomes.
- Providing learning opportunities: OPR places a research work in the context of a discussion, and gives authors, readers and others a chance to better understand the process from the initial manuscript submission to final published version.
- Exposing possible conflicts of interest: OPR may help to expose possible conflicts of interest in some cases.
Adoption of OPR by publishers (Wolfram etal., 2020) [1]
A summary of the most prolific publishers contributing to OPR and their headquarters country appears below. Although many journals today attract an international audience and are managed by international teams of researchers, the prevalence of OPR journals associated with publishers based in Europe stands out. Twenty-four of the 38 (63.2%) identified publishers are based in Europe and account for 445 out of the 617 titles (72.1%). Although the publishers are based in Europe, many of the journals they publish may support journals originating from other areas of the world (e.g., Kowsar). Furthermore, 500 of the OPR journals (81.0%) are published by only five publishers (MDPI, SDI, BioMed Central, Frontiers Media S.A., Kowsar). This points to the important role that publishers have played to date in the promotion of OPR (Wolfram etal., 2020) [1].
Publisher | OPR journals | Percentage of OPR journals (%) | Headquarters location |
MDPI | 204 | 33.0 | Switzerland |
SDI | 111 | 18.0 | India |
BioMed central | 70 | 11.3 | United Kingdom |
Frontiers media S.A | 64 | 10.4 | Switzerland |
Kowsar | 51 | 8.3 | The Netherlands |
Wiley | 40 | 6.5 | USA |
Copernicus publications | 21 | 3.4 | Germany |
PLOS | 7 | 1.1 | USA |
Elsevier | 7 | 1.1 | The Netherlands |
EMBO press | 5 | 0.8 | Germany |
Other publishers | 37 | 6.0 | 11 countries* |
Total | 617 | 100.0 |
- *United Kingdom (19 journals), United States (9), Argentina (1), Bulgaria (1), Canada (1), France (1), Germany (1), Ireland (1), Kenya (1), The Netherlands (1), Switzerland (1)
Recent Biggest Discoveries and advances in Cancer (2024)
- Prognosis and Treatment of Gastric Cancer: A 2024 Update:
- In a review published in the journal Cancers, researchers examined the scientific literature from January 2024 related to gastric cancer. The study focused on prognosis and treatment options.
- Apart from surgery, which remains the primary treatment for gastric cancer, other significant approaches include immunotherapy and therapeutic targeting.
- A multidisciplinary approach involving nutritionists and psychologists is essential after gastric cancer surgery.
- Researchers also explored markers in circulation that could help assess and validate treatment outcomes for patients with gastric cancer [2].
- Advances in Deep Learning for Cancer Treatment:
- An editorial in the journal Cancers discusses innovations shaping the future of cancer treatment. These include:
- Artificial intelligence (AI) in medical imaging
- AI applications in cancer diagnosis and treatment
- Challenges in medical image analysis
- Advancements in cancer detection techniques
- Innovations in skin cancer classification [3].
- An editorial in the journal Cancers discusses innovations shaping the future of cancer treatment. These include:
- New Targeted Therapies in Cancer:
- The journal International Journal of Molecular Sciences (IJMS) features a special issue highlighting recent discoveries in targeted therapies for cancer. This includes various molecules, alternative therapeutic strategies, and novel targets [4].
- Systematic Analysis Identifies Priority Drug Targets:
- Researchers conducted a systematic analysis of cancer cells and identified 370 candidate priority drug targets across 27 cancer types, including breast, lung, and ovarian cancers.
- By examining multiple layers of functional and genomic information, they gained insights into what enables cancer cells to grow and survive [5].
References
- Wolfram, D., Wang, P., Hembree, A. et al. Open peer review: promoting transparency in open science. Scientometrics 125, 1033–1051 (2020). https://link.springer.com/article/10.1007/s11192-020-03488-4
- Burz, C.; Pop, V.; Silaghi, C.; Lupan, I.; Samasca, G. Prognosis and Treatment of Gastric Cancer: A 2024 Update. Cancers2024, 16, 1708. https://doi.org/10.3390/cancers16091708
- Ijaz, M.F.; Woźniak, M. Editorial: Recent Advances in Deep Learning and Medical Imaging for Cancer Treatment. Cancers2024, 16, 700. https://doi.org/10.3390/cancers16040700
- IJMS | Special Issue : New Targeted Therapies in Cancer-2024 – MDPI. https://www.mdpi.com/journal/ijms/special_issues/34W678M09G
- Clare Pacini, Emma Duncan, Emanuel Gonçalves, James Gilbert, Shriram Bhosle, Stuart Horswell, Emre Karakoc, Howard Lightfoot, Ed Curry, Francesc Muyas, Monsif Bouaboula, Chandra Sekhar Pedamallu, Isidro Cortes-Ciriano, Fiona M. Behan, Lykourgos-Panagiotis Zalmas, Andrew Barthorpe, Hayley Francies, Steve Rowley, Jack Pollard, Pedro Beltrao, Leopold Parts, Francesco Iorio, Mathew J. Garnett. A comprehensive clinically informed map of dependencies in cancer cells and framework for target prioritization. Cancer Cell, 2024; DOI: 10.1016/j.ccell.2023.12.016
About IRP: Proofreading & Editing Services
IRP: Editing Services | Proofreading Services provides fast, high-quality professional editing and proofreading. Clients can select their preferred professional editor at any time, with 24/7 availability, and communicate with the editor throughout the entire process.